Association between serum levels of n-3 polyunsaturated fatty acids and coronary plaque detected by coronary computed tomography angiography in patients receiving statin therapy

Circulation Journal

Volumn 77, Issue 10, 2013, Pages 2578-2585

  Urabe, Yoji ^a   Yamamoto, Hideya ^a   Kitagawa, Toshiro ^a   Utsunomiya, Hiroto ^a   Tsushima, Hiroshi ^a   Tatsugami, Fuminari ^a   Awai, Kazuo ^a   Kihara, Yasuki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Coronary computed tomography angiography; Coronary plaques; Eicosapentaenoic acid; N 3 polyun saturated fatty acid

Indexed keywords

ATORVASTATIN; DOCOSAHEXAENOIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; PITAVASTATIN; ROSUVASTATIN; TRIACYLGLYCEROL;

AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84884649721     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-0257     Document Type: Article

References (38)

1. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495-1504.
2. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352: 1425-1435.
3. Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, et al. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: A multi-center randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary syndrome] study). J Am Coll Cardiol 2009; 54: 293-302.
4. Massaro M, Zampolli A, Scoditti E, Carluccio MA, Storelli C, Distante A, et al. Statins inhibit cyclooxygenase-2 and matrix metalloprotein-ase-9 in human endothelial cells: Anti-angiogenic actions possibly contributing to plaque stability. Cardiovasc Res 2010; 86: 311-320.
5. Sachdeva A, Cannon CP, Deedwania PC, Labresh KA, Smith SC Jr, Dai D, et al. Lipid levels in patients hospitalized with coronary artery disease: An analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J 2009; 157: 111-117.
6. Iso H, Kobayashi M, Ishihara J, Sasaki S, Okada K, Kita Y, et al. Intake of fsh and n3 fatty acids and risk of coronary heart disease among Japanese: The Japan Public Health Center-based (JPHC) study cohort I. Circulation 2006; 113: 195-202.
7. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105: 1897-1903.
8. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised open-label, blinded endpoint analysis. Lancet 2007; 369: 1090-1098.
9. Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 polyun-saturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 2009; 54: 585-594.
10. Cawood AL, Ding R, Napper FL, Young RH, Williams JA, Ward MJ, et al. Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque infam-mation and increased stability. Atherosclerosis 2010; 212: 252-259.
11. Mozaffarian D, Wu JH. (n-3) Fatty acids and cardiovascular health: Are effects of EPA and DHA shared or complementary? J Nutr 2012; 142: 614S-625S.
12. Russo V, Zavalloni A, Bacchi-Reggiani ML, Buttazzi K, Gostoli V, Bartolini S, et al. Incremental prognostic value of coronary CT angi-ography in patients with suspected coronary artery disease. Circ Cardiovasc Imaging 2010; 3: 351-359.
13. Kitagawa T, Yamamoto H, Horiguchi J, Ohhashi N, Tadehara F, Shokawa T, et al. Characterization of noncalcifed coronary plaques and identifcation of culprit lesions in patients with acute coronary syndrome by 64-slice computed tomography. JACC Cardiovasc Imaging 2009; 2: 153-160.
14. Motoyama S, Kondo T, Sarai M, Sugiura A, Harigaya H, Sato T, et al. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol 2007; 50: 319-326.
15. Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H, et al. Early statin treatment in patients with acute coronary syndrome: Demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: The ESTABLISH Study. Circulation 2004; 110: 1061-1068.
16. Kitagawa T, Yamamoto H, Horiguchi J, Ohashi N, Kunita E, Utsunomiya H, et al. Effects of statin therapy on non-calcifed coronary plaque assessed by 64-slice computed tomography. Int J Car-diol 2011; 150: 146-150.
17. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-1334.
18. Ohashi N, Yamamoto H, Horiguchi J, Kiagawa T, Hirai N, Ito K, et al. Visceral fat accumulation as a predictor of coronary artery calcium as assessed by multislice computed tomography in Japanese patients. Atherosclerosis 2009; 202: 192-199.
19. Kitagawa T, Yamamoto H, Ohhashi N, Okimoto T, Horiguchi J, Hirai N, et al. Comprehensive evaluation of noncalcifed coronary plaque characteristics detected using 64-slice computed tomography in patients with proven or suspected coronary artery disease. Am Heart J 2007; 154: 1191-1198.
20. Hirai N, Horiguchi J, Fujioka C, Kiguchi M, Yamamoto H, Matsuura N, et al. Prospective versus retrospective ECG-gated 64-detector coronary CT angiography: Assessment of image quality, stenosis, and radiation dose. Radiology 2008; 248: 424-430.
21. Raff GL, Abidov A, Achenbach S, Berman DS, Boxt LM, Budoff MJ, et al. SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography. J Cardiovasc Comput Tomogr 2009; 3: 122-136.
22. Kunita E, Yamamoto H, Kitagawa T, Ohashi N, Utsunomiya H, Oka T, et al. Association between plasma high-molecular-weight adipo-nectin and coronary plaque characteristics assessed by computed tomography angiography in conditions of visceral adipose accumulation. Circ J 2012; 76: 1687-1696.
23. 14C]eicosa-pentaenoic acid by human platelets. Thromb Res 1982; 28: 285-298.
24. Tamura Y, Hirai A, Terano T, Takenaga M, Saitoh H, Tahara K, et al. Clinical and epidemiological studies of eicosapentaenoic acid (EPA) in Japan. Prog Lipid Res 1986; 25: 461-466.
25. Simopoulos AP. Omega-3 fatty acids in infammation and autoimmune diseases. J Am Coll Nutr 2002; 21: 495-505.
26. Yamada H, Yoshida M, Nakano Y, Suganami T, Satoh N, Mita T, et al. In vivo and in vitro inhibition of monocyte adhesion to endothe-lial cells and endothelial adhesion molecules by eicosapentaenoic acid. Arterioscler Thromb Vasc Biol 2008; 28: 2173-2179.
27. Schwab JM, Chiang N, Arita M, Serhan CN. Resolvin E1 and pro-tectin D1 activate infammation-resolution programmes. Nature 2007; 447: 869-874.
28. Serhan CN, Chiang N, Van Dyke TE. Resolving infammation: Dual anti-infammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008; 8: 349-361.
29. Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D. Primary prevention of cardiovascular mortality and events with statin treatments: A network meta-analysis involving more than 65,000 patients. J Am Coll Cardiol 2008; 52: 1769-1781.
30. Ueeda M, Doumei T, Takaya Y, Shinohata R, Katayama Y, Ohnishi N, et al. Serum n-3 polyunsaturated fatty acid levels correlate with the extent of coronary plaques and calcifcations in patients with acute myocardial infarction. Circ J 2008; 72: 1836-1843.
31. Amano T, Matsubara T, Uetani T, Kato M, Kato B, Yoshida T, et al. Impact of omega-3 polyunsaturated fatty acids on coronary plaque instability: An integrated backscatter intravascular ultrasound study. Atherosclerosis 2011; 218: 110-116.
32. Kashiyama T, Ueda Y, Nemoto T, Wada M, Masumura Y, Matsuo K, et al. Relationship between coronary plaque vulnerability and serum n-3/n-6 polyunsaturated fatty acid ratio. Circ J 2011; 75: 2432-2438.
33. Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD, et al. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 2000; 71: 1085-1094.
34. Lee SH, Shin MJ, Kim JS, Ko YG, Kang SM, Choi D, et al. Blood eicosapentaenoic acid and docosahexaenoic acid as predictors of all-cause mortality in patients with acute myocardial infarction: Data from Infarction Prognosis Study (IPS) Registry. Circ J 2009; 73: 2250-2257.
35. Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, et al. Risk factors of atherosclerotic diseases: Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerosis cardiovascular diseases for Japanese. J Atheroscler Thromb 2007; 14: 267-277.
36. Matsuzaki M, Yokoyama M, Saito Y, Origasa H, Ishikawa Y, Oikawa S, et al. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease. Circ J 2009; 73: 1283-1290.
37. Domei T, Yokoi H, Kuramitsu S, Soga Y, Arita T, Ando K, et al. Ratio of serum n-3 to n-6 polyunsaturated fatty acids and the incidence of major adverse cardiac events in patients undergoing percutaneous coronary intervention. Circ J 2012; 76: 423-429.
38. Jula A, Marniemi J, Ronnemaa T, Virtanen A, Huupponen R. Effects of diet and simvastatin of fatty acid composition in hypercholesterol-emic men: A randomized controlled trial. Arterioscler Thromb Vasc Biol 2005; 25: 1952-1959.